Welcome to our dedicated page for Blade Air Mobility news (Ticker: BLDE), a resource for investors and traders seeking the latest updates and insights on Blade Air Mobility stock.
Blade Air Mobility, Inc. reported developments for a technology-powered air mobility platform that provided hospital air transportation and logistics, including human organ transport, and passenger helicopter and fixed-wing services in the Northeast United States and Southern Europe. Recurring updates covered operating results, medical revenue trends, conference presentations, and the company's asset-light service model supported by terminal infrastructure and proprietary technologies.
Company news also addressed electric aviation integration, including collaboration with advanced air mobility manufacturers and participation in an electric passenger flight. After the completed sale of the Passenger business and the name change to Strata Critical Medical, the public-company story centers on critical medical logistics and clinical services.
Blade Air Mobility (Nasdaq: BLDE) announced its participation in two upcoming investor conferences. The company will take part in the Bank of America Transportation, Airlines, and Industrials Conference on May 16, 2024, where CEO Rob Wiesenthal will join a fireside chat at 8:45 AM ET. Additionally, Blade will participate in the J.P. Morgan 52nd Annual Global Technology, Media, and Communications Conference on May 21, 2024, with CFO Will Heyburn featured in a fireside chat at 5:05 PM ET. Webcasts of both events will be available online.
Blade Air Mobility reported strong financial results for the first quarter ended March 31, 2024. The company achieved record-high Medical revenue of $36.0 million, a 34.6% increase from the prior year. Net loss improved by $6.0 million to $(4.2) million. Adjusted EBITDA also improved significantly. Blade confirmed guidance for Adjusted EBITDA profitability in 2024 and double-digit millions for 2025.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.